Sichuan Kelun Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Sichuan Kelun Pharmaceutical Co Ltd cash flow-to-debt ratio. Sichuan Kelun Pharmaceutical Co Ltd (002422) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥537.31 Million could theoretically repay 0% of its total liabilities (CN¥11.48 Billion) in one year. Check Sichuan Kelun Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
Cash flow-to-debt ratio of Sichuan Kelun Pharmaceutical Co Ltd from 2007 to 2025. Historical debt coverage capacity for Sichuan Kelun Pharmaceutical Co Ltd across 19 annual periods. Check how high is Sichuan Kelun Pharmaceutical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Sichuan Kelun Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2007–2025)
Sichuan Kelun Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Sichuan Kelun Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Sichuan Kelun Pharmaceutical Co Ltd (002422) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | CN¥2.64 Billion | CN¥10.54 Billion | ▼ -41.0% |
| 2024 | 0.42x | CN¥4.49 Billion | CN¥10.58 Billion | ▲ +7.0% |
| 2023 | 0.40x | CN¥5.34 Billion | CN¥13.44 Billion | ▲ +120.1% |
| 2022 | 0.18x | CN¥3.13 Billion | CN¥17.33 Billion | ▲ +10.3% |
| 2021 | 0.16x | CN¥2.85 Billion | CN¥17.41 Billion | ▲ +32.7% |
| 2020 | 0.12x | CN¥2.22 Billion | CN¥18.01 Billion | ▼ -2.3% |
| 2019 | 0.13x | CN¥2.22 Billion | CN¥17.58 Billion | ▼ -30.0% |
| 2018 | 0.18x | CN¥2.95 Billion | CN¥16.40 Billion | ▲ +139.6% |
| 2017 | 0.08x | CN¥1.20 Billion | CN¥16.01 Billion | ▼ -48.0% |
| 2016 | 0.14x | CN¥1.73 Billion | CN¥11.94 Billion | ▲ +33.1% |
| 2015 | 0.11x | CN¥1.24 Billion | CN¥11.42 Billion | ▼ -8.9% |
| 2014 | 0.12x | CN¥1.22 Billion | CN¥10.23 Billion | ▼ -10.2% |
| 2013 | 0.13x | CN¥1.05 Billion | CN¥7.92 Billion | ▲ +93.1% |
| 2012 | 0.07x | CN¥402.77 Million | CN¥5.87 Billion | ▼ -49.3% |
| 2011 | 0.14x | CN¥342.93 Million | CN¥2.53 Billion | ▲ +60.5% |
| 2010 | 0.08x | CN¥149.29 Million | CN¥1.77 Billion | ▼ -41.0% |
| 2009 | 0.14x | CN¥250.69 Million | CN¥1.75 Billion | ▼ -5.2% |
| 2008 | 0.15x | CN¥221.08 Million | CN¥1.47 Billion | ▼ -1.9% |
| 2007 | 0.15x | CN¥168.42 Million | CN¥1.10 Billion | — |